Back to Top Skip to main content Skip to sub-navigation

Military Health System participating in COVID-19 vaccine trial

Image of Woman measuring out a vaccine into a needle. Five military medical treatment facilities are participating in a Phase 3 clinical trial testing a COVID-19 vaccine in development with AstraZeneca. (Photo by Air Force Staff Sgt. Joshua Garcia.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine | Vaccine Trials

Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed.  The DOD sites are actively enrolling study participants, with a goal to recruit up to 1,000 volunteers in each of the three market areas towards the total AstraZeneca clinical trial enrollment of 30,000 people.

Operation Warp Speed, a multiagency U.S. Government effort led by the Department of Health and Human Services and the Department of Defense, is working with the private sector with the aims to deliver safe and effective COVID-19 vaccine doses to the American public beginning January 2021.

OWS is funding clinical trials evaluating several vaccine candidates which were selected based on promising data on safety, immune response, and protection in animal studies and safety and immune response data in early-stage trials in humans. Each of the trials is designed to collect data on how well a vaccine candidate protects against COVID-19 and on the safety of the vaccine candidate in a larger population, including people most at risk.  

“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” said Thomas McCaffery, assistant secretary of Defense for Health Affairs. “Now that vaccines have passed the first phases of testing for safety, dosing, and response, we have moved into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites supporting these next steps in the vaccine development process.”

Large phase 3 clinical trials are a necessary part of the rigorous scientific process to test the efficacy and safety of a vaccine in a real-world setting with a large population sample, said Air Force Col (Dr.) Jessica Cowden, chief medical officer of the DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnology Vaccine Acceleration Project.

“Phase 3 studies are designed to evaluate if the vaccine can prevent disease in the populations of people that the vaccine is being developed to protect,” said Cowden. “Phase 3 studies are large and usually involve some people who are at risk for infection and disease.”

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health established a network of infectious disease experts and research partners, termed the Coronavirus Prevention Network, or CoVPN, to rapidly and thoroughly evaluate U.S. government-sponsored COVID-19 vaccines. The CoVPN website (https://www.coronaviruspreventionnetwork.org/) provides general information about products being developed to prevent COVID-19 and about clinical trials.

According to the CoVPN, interested volunteers must be adults aged 18 and older to be screened for these initial trials. The CoVPN recognizes the importance of including volunteers who are more likely to get COVID-19, such as those over the age of 65 or with underlying medical conditions; as well as people who work in an essential job, live in a densely populated area, or represent a racial and ethnic group greatly impacted by the epidemic.

Representation by such groups matters in Phase 3 trials because vaccines need to be tested in populations who are at most risk of being exposed to the disease and getting sick in the real world, explained Cowden. “At-risk populations shouldn’t bear a disproportionate burden of research, but they need to be represented,” she said

The selected DoD sites are currently enrolling volunteers for the AstraZeneca clinical trial, according to Cowden. The trial is a randomized control, double-blind study, meaning volunteers will either receive the study vaccine or saline. “The study team and the participant will be blinded so that they won’t know which the participant received until the end of the study,” Cowden said. AstraZeneca’s vaccine candidate is in late-stage clinical trials ongoing in the U.K., Brazil and South Africa.

“Participating in a vaccine clinical trial is voluntary but is also critically vital to ensure that the overall effort is ultimately successful,” said Dr. Sean Biggerstaff, acting deputy director, DHA Research and Development Directorate. “Volunteers should also know safety remains an overriding priority for anyone participating in clinical trials.”

Military health beneficiaries who wish to volunteer for the AstraZeneca COVID-19 vaccine at a nearby military medical treatment facility (or at a civilian site close to home) can contact the local study team directly to request more information or can register on the CoVPN website and consent to be contacted by a research team. If registering on the CoVPN site, interested volunteers should enter the appropriate code in parenthesis from the list below, or enter their ZIP code to join the registry. Site contact information is included here:

At this point, the DOD is only participating in the AstraZeneca study. Additional DOD sites are being prepared for participation in other clinical trials of vaccines and monoclonal antibodies to prevent COVID-19, said Cowden.

“Having a safe and effective COVID-19 vaccine is what we need to protect people and get life back to normal, but in order to get to that point, we have to do these clinical trials,” explained Cowden. “These big Phase 3 clinical trials with a lot of people participating are critical so we can get the information we need to determine if a vaccine candidate is safe and can prevent COVID-19.”

You also may be interested in...

COVID19 Screensaver Prevention

Infographic
5/12/2021
COVID19 Screensaver Prevention

COVID Screensaver Prevention

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19

Hand Sanitizer with Methanol

Infographic
5/12/2021
Hand Sanitizer with Methanol

You should avoid using hand sanitizers that contain the wood alcohol, Methanol.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19

Hand Sanitizer Parent and Child

Infographic
5/12/2021
Hand Sanitizer Parent and Child

Parent giving child hand sanitizer

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19

Is it COVID or Allergies Main

Infographic
5/12/2021
Is it COVID or Allergies Main

How to tell the difference between allergies and COVID-19

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Symptoms of COVID-19

Teleworking New Normal Stand Up

Infographic
5/12/2021
Teleworking New Normal Stand Up

Stand up while teleworking

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Staying Resilient

Teleworking New Normal Exercise

Infographic
5/12/2021
Teleworking New Normal Exercise

Exercise while teleworking

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Staying Resilient

Teleworking The New Normal

Infographic
5/12/2021
Teleworking The New Normal

Tools on how to telework during the COVID-19 social distancing guidance

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Staying Resilient

Is It Allergies or COVID-19?

Infographic
5/11/2021
Is It Allergies or COVID-19?

This Infographic provides a chart that outlines how to tell the difference between COVID-19 and allergy symptoms

Recommended Content:

Symptoms of COVID-19 | Coronavirus | Coronavirus and the COVID-19 Vaccine

Vaccines Save Lives

Infographic
5/6/2021
Vaccines Save Lives

Infographic showing that vaccines work and save lives. Includes a black and white image on the top half listing polio and smallpox on the left hand side. Includes a QR code to schedule vaccination appointments, and the TRICARE logo on the bottom right of the page.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

VAX Fact Other Medical Conditions

Infographic
4/19/2021
VAX Fact Other Medical Conditions

An infographic answering the question of whether you can get the COVID-19 vaccine if you have underlying medical conditions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Protection Last

Infographic
4/19/2021
VAX Fact Protection Last

An infographic answering the question of how long the COVID-19 vaccine protection lasts.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Affect Fertility

Infographic
4/19/2021
VAX Fact Affect Fertility

An infographic answering the question of whether the COVID-19 vaccine affects a person's fertility.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Currently Pregnant

Infographic
4/19/2021
VAX Fact Currently Pregnant

An infographic answering the question of whether to get the COVID-19 vaccine if you're currently pregnant.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Breastfeeding

Infographic
4/19/2021
VAX Fact Breastfeeding

An infographic answering the question of whether you can get the COVID-19 vaccine if you're breastfeeding.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Current Infection

Infographic
4/19/2021
VAX Fact Current Infection

An infographic answering the question of whether to get the COVID-19 vaccine if you currently have a positive COVID-19 infection.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts
<< < 1 2 3 4 5  ... > >> 
Showing results 46 - 60 Page 4 of 6
Refine your search
Last Updated: August 09, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.